Swathi Namburi, MD

Swathi Namburi, MD, is a hematologist who specializes in treating a variety of blood cancer and blood disorders. Her clinical research interests include multiple myeloma and novel immunotherapy approaches for blood cancers.

Dr. Namburi is part of the Center for Blood Disorders and Cellular Therapy at the Swedish Cancer Institute. She provides full-spectrum care for her patients. This includes initial consultation and diagnosis, treatment to help achieve remission, consideration and enrollment onto clinical trials open through Providence/Swedish health care, and long-term management and survivorship related care. She oversees her patients through CAR-T cell therapy and autologous stem cell transplantation as these needs come up during various phases of treatment.

Dr. Namburi completed a fellowship in hematology/oncology at the University of Pittsburgh Medical Center. She completed her residency at the George Washington University Medical Center in DC, and prior to that attended medical school at Rutgers/UMDNJ in New Brunswick, NJ near to where she grew up in East Brunswick, NJ. She is board certified in internal medicine, medical oncology, and hematology. She can communicate in several languages including Telugu, Hindi, Spanish, and French and she liberally receives help from Swedish’s wonderful in-person medical translators.

Dr. Namburi has been practicing in the Seattle-Tacoma region since 2018. She is a board member of the Washington State Medical Oncology Society and participates in the annual Washington State Medical Association meetings to help support state initiatives that will help our patients with cancer have access to excellent care and treatment. She regularly attends and presents her work at national and international hematology conferences.